CGRP-pathway exposure during the pre-EBP interval in spontaneous intracranial hypotension: an exploratory retrospective case series.

Emgality (galcanezumab-gnlm) - Eli Lilly, Daiichi Sankyo

Ajovy (fremanezumab-vfrm) - Teva

Qulipta (atogepant) - AbbVie

Nurtec ODT (rimegepant ODT) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42432562

Chung-Yao Yin; Fu-Chi Yang; I-Fang Yang; Kai-Hsiang Chang; Yi-Chih Hsu; Yu-Chin An

Jul 11, 2026